. However, one aspect that has not been fully explored is whether other hormones of the hypothalamus-pituitarygonadal (HPG)-axis have a role in menopause-associated cognitive dysfunction and increased susceptibility to develop AD. In other words, is estrogen the sole modulator of cognitive function or rather does estrogen act as part of a feedback loop, similar to its role in reproductive function. To this end, a growing body of evidence demonstrates that the entire molecular repertoire associated with the HPG-axis is found in the brain, that HPG components, in addition to estrogen, have cognitive modulating properties (Ishii et al. 2007) , and that hormones not commonly associated with CNS function confer CNS protective effects (Mukerji et al. 2007) .
Post-menopausal women show large increases in the concentration of serum LH and FSH (Chakravarti et al. 1976 ) that result from lack of negative-feedback of estrogen on gonadotropin-releasing hormone (GnRH) (Couzinet and Schaison 1993) . Of interest, there is evidence suggesting that LH may have CNS modulating properties. In fact, LH receptors are present in the brain (Lei et al. 1993; Hamalainen et al. 1999; Apaja et al. 2004) and, like E2 receptors, are highly expressed in the hippocampus (Lei et al. 1993 ), a key brain area responsible for cognition affected by aging and severely deteriorated in AD. Similarly, both LH and steroidogenic acute regulatory protein (StAR), the rate-limiting step in steroidogenesis and is regulated by LH (Stocco and Clark, 1996) have been found in the brain and co-localize in pyramidal neurons . With regards to cognition, in vivo studies also support a role of gonadotropins on cognitive function. For example, infusion of human chorionic gonadotropin (hCG), which is 84% homologous to LH, shares the same receptor and is capable of modulating various behaviors (Lukacs et al. 1995) , and even in the presence of E2 is detrimental to cognition (Berry et al. 2008) . Furthermore, we recently showed that LHb overexpression leads to cognitive dysfunction in a receptor specific manner (Casadesus et al. 2007) and that abolishing serum LH in aged amyloid-b protein precursor overexpressing transgenic mice (Tg2576), using the selective GnRH agonist, leuprolide acetate (LA) that markedly reduces serum LH through receptor down-regulation (Schally and Nagy 2001; Bowen et al. 2004) sustains cognitive performance, and lowers amyloid-b deposition . Clinically, two recent studies correlate poor memory function and an increased incidence of AD with high levels of LH (Rodrigues et al. 2008 ) and levels of LH positively correlate with serum amyloid-b levels in older men .
Importantly, in the rat, the suppression of LH and GnRH by estrogen is reduced during aging (Lloyd et al. 1994; Romero et al. 1994) and estrogen becomes less effective at reducing LH the later that estrogen therapy is started after ovariectomy (OVX) in rats (King et al. 1987) and in women (Rossmanith et al. 1994; Weiss et al. 2004) . This sensitivity change parallels the effect of estrogen on cognition (Sherwin 2005; Daniel et al. 2006) , such that estrogen therapy, begun a long interval after menopause or OVX fails to improve cognition whereas short delays before the onset of estrogen treatment are effective. As such, the effects of estrogen on cognition and neuronal function may be, at least partially associated with the ability of estrogen to down-regulate gonadotropins. Nevertheless, to date there is virtually no information on the actions of high levels of gonadotropins on memory sensitive areas such as the hippocampus. Therefore, to address the question we examined the effects of estrogen or GnRH receptor inhibition (and concurrent down-regulation of gonadotropins) on cognitive function and memoryassociated signaling after ovariectomy. The characterization of such mechanisms may offer novel therapeutic opportunities for the treatment of post-menopausal/age-related cognitive decline.
Materials and methods

Animals and housing
Forty female C57/BL6 mice were purchased from Jackson Labs (Bar Harbor, ME, USA). All animals were group housed upon arrival, provided ad libitum access to food and water, and maintained on a 12-h light/dark cycle. All animals were treated following approved protocols by The Institutional Animal Care and Use Committee of Case Western Reserve University and experimental groups were determined in a random fashion. All animals were weighed three times during the study as general measure of health status.
Ovariectomy, pellet implantation, and LA treatment All animals were either ovariectomized (n = 30) or sham-treated (n = 10) as previously described (Frick and Berger-Sweeney 2001) at Jackson Laboratories prior to transportation. Briefly, mice were anesthesized with ketamine and xylazine and their ovaries, oviducts, and tips of the uterine horn were bilaterally removed via two dorsal incisions (OVX). Sham controls underwent an identical surgical procedure but without removing ovaries, oviducts, and tips of the uterine horn. Additionally, all animals were subcutaneously implanted with 90-day timed-release pellet (Innovative Research of America, Sarasota, FL, USA) containing either 0.18 mg of 17b-estradiol (E2) or placebo, matched to the inert ingredients of the experimental pellet. This dose of E2 replacement was chosen based on previous studies reporting positive effects on cognition in C57/ BJ6 mice (Heikkinen et al. 2002) .
After the surgery all animals were treated with a 1% acetaminophen solution in their drinking water and topical antibiotic ointment to the wound for postoperative analgesia and transported to our facility 24 h after surgeries. Two days post-surgery animals received either LA [7.5 mg/kg, slow release (depot) formulation] or physiological 0.9% saline injected intra-muscularly twice monthly for a duration of 3 months. We have shown that this dose regimen successfully abolishes LH levels in these mice and is effective at modulating cognitive function in the Tg2576 transgenic mouse .
Cognitive testing
Y-maze
Two weeks prior to the end of treatment, we measured Y-maze performance, a general test of cognitive function with a hippocampal component, and exploratory activity. The Y-maze test was [32 cm (long) · 10 cm (wide) with 26-cm walls]. Briefly, each animal was placed in one of three arms of the Y-maze (alternating arms across animals in each group) and each arm entry was recorded for 6 min. An alternation was defined as three entries in three different arms (i.e., 1, 2, 3 or 2, 3, 1, etc.). Percent number of alternations was calculated as (total alternations/total number of entries -2)*100. The maze was cleaned with ethanol between each animal to minimize odor cues.
Morris water maze
One week prior to the end of treatment, the Morris water maze (MWM) task, a task highly sensitive to hippocampal changes, was used to examine spatial learning and memory in all experimental treatments following previously published methodology (Fugger et al. 1998) . Animals were trained in a black circular pool (3-feet in diameter) in a room containing distal visual cues. Pool water was whitened with non-toxic white dye and temperature maintained at 23°C. A white escape platform (10.5 cm in diameter) located approximately 0.5 cm beneath the water level was placed in the center of the NE quadrant of the pool. Animals were introduced into the pool from different quadrants to control for location bias and were tested 12 trials per day, subdivided into three blocks, over 3 days. A pre-training session in which all animals were allowed to swim in the pool, and were gently guided to the platform was also performed. The training trial began by delicately placing the animal in the water from one of the four start positions at the edge of each quadrant and allowing it to swim for 60 s. If the animal did not find the platform during the allocated task time, it was gently guided towards the platform where it remained for 15 s and then immediately placed back into the water from the next start position for the next trial. The exact procedure was followed for four trials (one from each start position), at which point the mouse was dried and placed back into its home-cage (warmed with a heating pad) for 30 min until the start of the next trial block. Swim time, path length, and swim speed was recorded using a video tracking system and software (Ethovision, Noldus Information Technology, Wageningen, The Netherlands). On day 3, the platform was placed in the same position as day 1 for 11 trials, and the platform removed on the 12th trial for a probe trial to measure retention of spatial information. After the platform was removed, the animals were allowed to swim for 60 s without the possibility to escape; percent time spent in the quadrant where the platform was previously located, proximity (average distance to the platform in cm) and platform crossings (the number of times the animal crosses the exact location) were measured. At the end of training the platform was rendered visible and all animals underwent a session to test for visual acuity.
RT-PCR
Total RNA was extracted from mouse hippocampus using the RNeasy kit (Qiagen, Valencia, CA, USA) (n = 4-6/group). This was converted to cDNA using the RETROscript RT-PCR kit (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Briefly, the purified total RNA (100 ng) was reverse transcribed with cloned Moloney murine leukemia virus reverse transcriptase (50 U) by incubating at 44°C for 60 min, followed by heating at 92°C for 10 min. The resulting single-stranded cDNA was then amplified using a pair of primers for each target gene (25 pmol) and Taq DNA polymerase (2.5 U). The RT-PCR products were then subjected to 1.5% agarose gel electrophoresis. DNA in each sample was quantified using the imaging system. Gene expression was normalized by expression of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and quantified relative to the other groups. Primer sequences for each gene were as follows:
PCR amplification consisted of 27 cycles (45 s at 94°C for denaturing, 45 s at 60°C for primer annealing, and 45 s at 72°C for primer extension).
Real-time RT-PCR
Real time RT-PCR was used to quantify relative Aromatase CYP19 gene expression (ABI TaqMan assay Mm00484049_m1) normalized to GAPDH (ABI TaqMan assay Mm99999915_g1). TaqMan PCR assays for each gene target were performed in triplicate on cDNA samples in 96-well optical plates on an ABI StepOne Plus (Applied Biosystems, Foster City, CA, USA). For each 20 lL TaqMan reaction, 2 lL cDNA was mixed with 10 lL 2· TaqMan Fast Universal PCR Master Mix (Applied Biosystems) and 1 lL of 20· TaqMan assay mix. Standard fast PCR parameters were used. Data are expressed as relative quantity (RQ value).
Western blotting
Hippocampal tissue was homogenized with lysis buffer (Cell Signaling, Beverly, MA, USA) and proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subsequently transferred onto a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA). Membranes were blocked with 10% (w/v) non-fat dry milk TBS-T [50 mM Tris pH 8.8, 150 mM NaCl and 0.05% (v/v) Tween 20] and incubated overnight with the primary antibody at 4°C in 5% bovine serum albumin-Tris-buffered saline-T (see Table 1 ). Binding of the primary antibody was detected with horseradish peroxidaseconjugated anti-IgG antibody (Table 1) , followed by the enhanced chemiluminescence detection system (Western blotting Luminol Reagent, Santa Cruz, Santa Cruz, CA, USA). Protein load was monitored using immunodetection of b-actin. Semi-quantitative values were obtained with the software Quantity One (Bio-Rad, Hercules, CA, USA). Results are expressed as arbitrary units of optical density.
Serum measurements
Serum measurements experimental animals (n = 5/group for E2 and n = 5/group for LH) were carried out at the Animal Reproduction and Biotechnology Laboratory at Colorado State University as previously described (Korenman et al. 1974; Nett et al. 1974) .
Results
Modulation of hippocampal learning and memory
Morris water maze
The MWM test is a test specific for hippocampal learning and memory. Repeated measures ANOVA analysis for escape latency showed a significant difference across our experimental groups (F = 2.820; p = 0.05) and a significant day*group interaction indicating that MWM learning was differentially modulated by our treatments (F = 2.694, p = 0.019) (Fig. 1) . Specifically, post-hoc analysis (Fisher LSD) indicated that OVX mice took significantly longer to locate the platform compared to sham operated animals (p = 0.024). This learning deficit was rescued by E2 (p = 0.033) and LA (p = 0.017). Importantly, there was a significant group difference across days (F = 92.061; p < 0.001), thus confirming training was successful.
To determine that swimming speed was not a confounding factor in our results, we determined differences in swimming velocity across groups. We found an expected significant difference in swim speed across days (F = 12.677; p = 0.001) but no significant differences between groups (p = 0.131) indicating swimming speed was similar in all our groups (data not shown).
To further characterize the impact of gonadotropin modulation on memory function, the capacity of the animals to use spatial information and retain this information was measured using a probe trial. At the end of the last day of training, the platform was removed and the animals were allowed to swim for 1 min. One way ANOVA analysis indicated a group difference in time spent in the quadrant that had previously contained the platform (F = 3.510; p = 0.023) (Fig. 2a) as well as in the latency to first enter the target quadrant (F = 4.289; p = 0.01) (Fig. 2b) . Specifically, OVX animals spent significantly less time in the target quadrant compared to sham operated mice (p = 0.015) and this was reversed both by E2 replacement (p = 0.017) and LA treatment (p = 0.018). Post-hoc analyses (Fisher LSD) indicated that OVX mice were significantly slower at entering the target quadrant when introduced to the pool compared to sham animals (p = 0.003). Both E2 replacement (p = 0.014) and LA treatment (p = 0.006) were able to reverse this slower response.
Y-maze
To validate and generalize our MWM behavioral findings the animals were tested in a second behavioral test. The Y-maze, a more general test of cognitive function with a hippocampal component able to detect OVX-associated cognitive deficits (Dumas 2004 ). As such one-way ANOVA analyses support the MWM findings, demonstrating a significant group difference (F = 3.997; p = 0.013). Post-hoc analyses (Fisher LSD) indicated that OVX deficits, measured by reduced % alternations, in the Y-maze task compared to sham (p = 0.013) were able to be rescued by LA treatment (p = 0.002) and E2 (p = 0.018) (Fig. 3) .
Modulation of estrogen-associated parameters
To determine the mechanisms associated with LA positive effects on cognition, we determined whether these effects resulted from increases in endogenous estrogen production or transcriptional modulation of the estrogen receptors. As such, we measured the levels of transcriptional activation of p450 aromatase (CYP19), StAR, and estrogen receptors a and b in the hippocampus of all groups. One-way ANOVA indicated a group difference in CYP19 expression (F = 12.202; p = 0.0001). Specifically, OVX resulted in a significant increase in CYP19 transcription compared to sham (p = 0.0001), E2 replacement (p = 0.0001) and LA treatment (p = 0.003). Interestingly LA, which depletes both levels of gonadotropins as well as gonadal hormones such as E2, also led to the down-regulation of p450 aromatase in the hippocampus of these animals, suggesting that gonadotropin increases, rather than estrogen depletion, is a driving factor in activating the transcription of CYP19 and production of endogenous estrogen (Fig. 4) .
To further evaluate the ability of LA to modulate estrogenassociated parameters we measured the transcription as well as the protein expression of StAR, the rate-limiting step of steroid synthesis (Clark and Stocco 1995) . Our results demonstrate that there was no significant changes in StAR mRNA expression across treatments (F = 0.388; p = 0.763). Nevertheless, western blot analysis for the mature StAR protein (30 kDa) but not the immature protein (37 kDa) showed a significant group difference (F = 3.539; p = 0.05).
Specifically our findings indicate that StAR protein expression was significantly up-regulated after OVX compared to sham (p = 0.03) and increased levels of StAR were significantly down-regulated (normalized) by E2 (p = 0.02) and LA (p = 0.023) (Fig. 5) .
Similarly, to determine the impact of our treatments on estrogen receptors (ER) a and ER b we measured the mRNA transcription of these receptors in all of our groups and found no significant group differences for ER a (F = 0.170; p = 0.915) or ER b (F = 0.384; p = 0.766) (Fig. 6) . Taken together these findings suggest that cognitive rescue observed in our LA treated group is unlikely to be driven through endogenous estrogen-associated mechanisms.
Modulation of memory associated signaling pathways
To investigate potential signaling pathways associated with our behavioral data, the levels of Ca 2+ /calmodulin-dependent protein kinase II (CAMKII) auto-phosphorylation (Thr286) which confers independent activity to CaMKII and is known to be necessary for long-term potentiation (LTP) activation (Rotenberg et al. 1996) were determined. Furthermore, we also determined downstream targets of CaMKII auto-phosphorylation such as phosphorylation of the a-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor glutamate receptor (GluR) 1 subunit at Ser831; also known to be important for the activation and maintenance of LTP (Barria et al. 1997) . Statistical analysis revealed a significant difference across groups (F = 15.965; p = 0.001). Notably, OVX lead to significant decreases in CaMKII-Thr286 compared sham operated animals (p = 0.001). This OVX related decrease was rescued by LA treatment (p = 0.009) but not by E2 (p = 0.227). Interestingly, our analysis also showed that E2 treatment was significantly decreased compared to sham (p = 0.001) and LA treatment (p = 0.001) (Fig. 7a) . CaMKII dependent modulation of the GluR1 subunit phosphorylation followed an identical trend with a significant group difference (F = 7.010; While StAR mRNA levels were unchanged across groups (a), protein was significantly increased following OVX and completely rescued to sham levels by either LA or E2. n = 3-6/group (b). *Statistical significant difference (p < 0.05) between OVX and OVX + LA, OVX and OVX + E2, and OVX and SHAM controls. mRNA expression of ER-a (a) and ER-b (b) was not significantly changed across groups. n = 3-6/group. Fig. 7 Protein expression of CaMKIIThr286 and GluR1-Ser831. OVX-related decreases in pCaMKII (a) and GluR-Ser831 (b) were completely rescued to sham levels by LA but unaffected by E2. n = 4-6/group. *Statistical significant difference (p < 0.05) between OVX and OVX + LA, OVX and OVX + E2, and OVX and SHAM controls. p = 0.01). Post hoc analyses revealed that both OVX (p = 0.005) and E2 replacement (p = 0.004) lead to significant decreases in GluR1-Ser831 phosphorylation. These decreases were successfully rescued by LA treatment compared to OVX (p = 0.04) but not by E2 replacement (p = 0.840). Furthermore, GluR1-Ser831 phosphorylation was significantly decreased in the E2 group compared to sham (p = 0.004) and LA treatment (p = 0.032) (Fig. 7b) .
To determine whether signaling changes were associated with our behavioral findings we carried out correlations between these measurements. A positive correlation between CaMKII-Thr286 levels and GluR1-Ser831 phosphorylation levels (r = 651; p = 0.022) was identified indicating an association between the phosphorylation pattern of these two proteins. Similarly, both CaMKII-Thr286 levels and GluR1-Ser831 protein levels were correlated with the probe trial measurements. Specifically, there was a significant negative correlation between CaMKII-Thr286 levels (r = )0.715; p = 0.009) and GluR1-Ser831 (r = )0.603; p = 0.049) and latency to enter the target quadrant, indicating a relationship between protein levels and their retention of the task.
There was no statistically significant difference in total CaMKII (F = 1.426; p = 0.288) and total GluR1 levels (F = 1.109; p = 0.387), indicating that these differences are indeed specific to increases in phosphorylation rather than changes in total CaMKII or GluR1 levels. Taken together, these data suggest that LA, but not E2, is able to modulate these key parameters associated with learning and memory. However, given that E2 treatment also improved cognitive function, these data suggest that E2 replacement and LA treatment may activate different cognition-associated signaling cascades.
Modulation of serum LH in OVX mice by LA To validate that the performed treatments modulated the target hormones according to expectations and that these levels were within physiological levels, radioimmunoassay measurements for LH and E2 were carried out. One way ANOVA revealed a significant group difference for both LH (F = 26.68; p = 0.0001) and E2 (F = 5.242; p = 0.008). Specifically, LH levels in the OVX group were significantly increased compared to sham (p = 0.0001), E2 (p = 0.0001) and LA treated animals (p = 0.0001). No significant differences were observed between sham, LA and E2 treated animals. Furthermore, statistically significant increases in E2 levels were found in the E2-replaced animals compared to sham (p = 0.014), OVX (p = 0.015) and LA (p = 0.007) treated animals compared to controls. While E2 replaced animals showed significantly higher levels of E2 compared to our sham control group, levels of E2 in our cohort of animals were within physiological levels for mice (12-85 pg/mL). Taken together, the surgical and pharmacological interventions resulted in the expected effects on both E2 and LH serum levels (Table 2) .
Discussion
The effect of menopausal increases in gonadotropins such as LH on cognition has not been previously studied. In this study, we show that down-regulation of gonadotropins leads to cognitive improvement both in the Y-maze and MWM maze in the absence of E2. LA is an established treatment to ablate gonadal hormones in hormone-sensitive cancer (Schally 2008) . Therefore, the fact that cognitive benefits were observed in the absence of gonadal steroids such as E2 suggest that the up-regulation of serum gonadotropins may be a key factor in the development of cognitive deficits associated with menopause and/or aging. This study grants further support to previous findings from our laboratory (Casadesus et al., , 2007 and others (Berry et al., 2008; Rodrigues et al., 2006) . Also important, an early study shows that infusion of LH can lead to activation of hippocampal activity, and in particular the subiculum, the main output of CA1 fibers (Gallo et al. 1971; Kovacs et al. 1974) indicating that the LH receptor in the hippocampus is functional.
Leuprolide acetate downregulates all gonadotropins including FSH. As such, the individual contribution LH and FSH on cognition and cognition-associated signaling remains to be determined. However, LH but not FSH receptors have been described in the hippocampus (Lei et al. 1993) . As such, our findings are likely to be associated with the modulation of LH rather than FSH. Another intriguing possibility is that cognitive improvement is driven by the direct modulation of the GnRH receptor. In this regard, hippocampal cultures, E2 synthesis, spine synapse density, and immunoreactivity of spinophilin have been shown to be up-regulated in a dose-dependent manner at low doses of GnRH but decreased at higher doses (Prange-Kiel et al. 2008) . One possibility that remains to be further studied is the fact that LA, while working as an ''antagonist'' at the pituitary level could be acting as a proper agonist in the brain. In this regard, while the dissection between GnRH and gonadotropin events on cognition is somewhat difficult as no LH specific antagonists are available preliminary data from our group indicate that the use of GnRH antagonists, which lead to similar down-regulation of gonadal steroids and gonadotropins but do not activate GnRH receptor (Schally and Nagy 2001; Schally 2008) , lead to similar cognitive Mechanistically, little is known regarding the molecular effects of high gonadotropins in the hippocampus or the cognitive-enhancing mechanisms associated with their downregulation. Recent reports indicate the presence of many parts of the HPG axis in the brain and the local hippocampal production of endogenous E2 on neuronal plasticity (Ishii et al. 2007) . Therefore, to determine whether LA exerted its beneficial effects through estrogen-related mechanisms this study examined the ability of LA to modulate the transcriptional activity of p450 aromatase, the enzyme responsible for aromatizing testosterone and esterone to E2, and one of the major mechanisms for local E2 production in the brain (Roselli et al. 1985; Hojo et al. 2004) . Previously published data indicate that OVX (and concurrent increase in LH) leads to up-regulation of p450 aromatase both in the pituitary (Galmiche et al. 2006 ) and the brain (Ye and Leung 2008) as such our findings are in accordance with these data. Furthermore, LH/hCG has been shown to increase p450 aromatase transcription in extra-gonadal tissues (Shayu and Rao 2006) and in mature Leydig cells (Genissel et al. 2001) , therefore down-regulation of p450 aromatase by LA, is consistent with this previously published work. Given that LA was able to down-regulate p450 aromatase transcription in an identical manner to that of E2 replacement our data suggest that high levels of LH rather than depletion of E2 may be the driving factor of activation of p450 aromatase transcription after depletion of gonadal hormones. How LA modulates p450 aromatase expression in the brain and the relationship between p450 aromatase modulation and the activation of GnRH and/or LH receptor are novel important avenues to pursue to gain a full understanding of HPG-axis dynamics on cognition and hippocampal neuronal function.
Steroidogenic acute regulatory protein transcription has also been shown to be intimately associated with local E2 production (Ishii et al. 2007) . Furthermore, LH is known to up-regulate StAR protein in the ovary (Stocco and Clark 1996) and in neuroblastoma cells , and LA has been shown to down-regulate StAR in cycling rats . Our data demonstrating that StAR protein expression is up-regulated by long-term OVX and down-regulated by LA and that within the cell, StAR processing from the cytosolic full-length form to the truncated inner mitochondrial membrane form is reduced following treatment with LA supports previously published findings (Meethal et al. 2009 ). Importantly, reports indicate that StAR transcription is not changed after gonad removal (Sierra 2004) . As such, our data are in line with this report as we did not find differences in StAR transcription across our groups. Taken together, these findings suggest that changes in StAR protein after OVX are likely to be driven by post-translational mechanisms. While this has never been elucidated in detail in the OVX model, previous reports show that StAR can undergo such modifications (Arakane et al. 1997) .
Finally, the literature is replete with contradictions regarding ER a and b transcriptional activity after OVX (Mohamed and Abdel-Rahman 2000; Iivonen et al. 2006) , partially because of differences in the type of estrogen as well as regiment and route that is used in OVX studies (Iivonen et al. 2006) . Furthermore, very few articles measure both transcription as well as protein expression. In our study we did not find any significant differences in the mRNA levels of these receptors. We did not carry out protein measures because of insufficient sample quantity. Nevertheless, despite not attaining differences between OVX and E2/sham which have been reported previously, but for protein (for review see McEwen 2002), the fact that LA treatment did not change the mRNA expression of these receptors suggests that LA does not work through the transcriptional modulation of these receptors.
Taken together our findings illustrate that OVX leads to up-regulation of mechanisms associated with local E2 production and that events that down-regulate this process are beneficial to cognitive function. Several reports indicate that local E2 production is associated with detrimental processes such as neuronal injury (Gazzaley et al. 1996; den Heijer et al. 2003; Sierra et al. 2003) and has been shown to activate neuroprotective mechanisms (Cimarosti et al. 2005; Veiga et al. 2005; Yue et al. 2005; Hilton et al. 2006; Hoffman et al. 2006) . Nevertheless, in chronic milder detrimental conditions such as OVX, local E2 production does not seem to be sufficient to improve cognitive function.
CaMKII auto-phosphorylation at residue Thr286 is crucial for LTP in the hippocampus, a well-studied form of synaptic plasticity, which is thought to contribute to learning and memory (for reviews see Lisman et al. 2002; Colbran and Brown 2004) . Both NMDA and AMPA receptors are critical for the induction of hippocampal LTP, the neurobiological correlate of learning and memory and modulated by aging (Wenk and Barnes, 2000) . For example, memory encoding has been shown to be attributable to NMDA receptors, while memory retrieval is dependent upon AMPA receptors (Bast et al. 2005) , reflected in our finding of AMPA receptor modulation following treatment, with the result of improved memory retention. To begin to address what molecular mechanisms were associated with our behavioral findings, we focused on CaMKII auto-phosphorylation and downstream targets such as the phosphorylation of the AMPA receptor (AMPAR) subunit GluR1 at the ser831 residue, as they have been shown to be key in the LTP process and hippocampal spatial learning and memory (Barria et al. 1997) . As such, the findings that we present indicate that OVX leads to downregulation of CaMKII auto-phosphorylation and CaMKII dependent GluR1 subunit phosphorylation, which was correlated with reduced retention in the probe trial. Importantly, down-regulation of gonadotropins lead to increases in these proteins suggesting that cognitive function improvements may be associated with the activation of LTP related mechanisms. Chronic E2 replacement did not produce upregulation of these proteins, indicating that E2 replacement and downregulation of gonadotropins exert cognitive benefits through different mechanisms. While E2 has been associated with LTP and been shown to rapidly upregulate CAMKII under acute treatment (Sawai et al. 2002) . Several reports indicate that E2 has differential effects depending on the chemistry surrounding E2 effects (Shiroma et al. 2005) and temporal spacing between measurement and E2 administration (Hojo et al. 2008) . As such, E2 effects have also been strongly associated with LTD (Ishii et al. 2007) . Therefore, based on our findings showing that chronic E2 treatment does not up-regulate mechanism associated with LTP, E2 improvements in cognitive function may be associated with LTD, also shown to be critical for cognitive function (Kessels and Malinow 2009 ). As such, long term, chronic treatment of E2 may (i) diphosphorylate GluR1-Ser831 or (ii) change the expression pattern of the GluR2 subunit (Kessels and Malinow 2009) leading to LTD. Future studies will need to examine AMPAR receptor subunits changes under the present conditions in more detail to further elucidate the relationship between LTP and LTD and our treatments. Furthermore, electrophysiological studies will need to be carried out to fully determine the role of E2 and down-regulation of gonadotropins on LTP/LTD mechanisms.
Conclusions
Menopause, a milestone event in the life of every woman, is characterized by major changes in the activity of the hypothalamic-pituitary-gonadal axis, leading to an abrupt decline in estrogen levels and high elevations of FSH and even higher elevations of LH. These hormonal changes predispose women to an increased risk of heart disease, bone loss, depression, and a gradual onset of cognitive decline and an increased risk for development of dementia such as AD. For the first time, here we present evidence demonstrating that down-regulation of gonadotropins in the absence of estrogen after OVX leads to cognitive improvement in mice. Importantly, we demonstrate that these effects are not mediated via the production of local estrogens and provide evidence demonstrating that cognitive improvement by E2 and LA are driven by independent cognition-related molecular mechanisms. This novel work expands the increasing number of HPG-axis hormones associated with neuronal processes, and more importantly, provide a potential new avenue of urgently needed therapies for post-menopausal/ age-related cognitive decline as well as potential protective treatments against the development of AD.
